| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Proquest Investments Iv, L.P. is a 10% Owner at URGN with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $38.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 22,100 | $70.06 | $1,548,326.00 | -0.5% | |
| Sep 29, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 77,900 | $70.04 | $5,456,116.00 | -1.7% | |
| Sep 21, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 99,795 | $66.17 | $6,603,416.03 | -1.1% | |
| Sep 8, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 70,925 | $62.50 | $4,432,862.85 | -0.4% | |
| Aug 24, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 28,870 | $63.00 | $1,818,671.06 | -0.3% | |
| Aug 17, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 99,795 | $61.36 | $6,123,170.01 | -0.3% |